Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Arboretum Ventures is a healthcare venture capital firm founded in 2002 and headquartered in Ann Arbor, Michigan. The firm has established itself as a key player in the healthcare investment landscape, focusing on early-stage companies that aim to improve patient outcomes while reducing healthcare costs. Arboretum Ventures has raised a total of approximately $1 billion across multiple funds, with its most recent fund, Fund VI, closing at $268 million in July 2023, exceeding its target.
The firm primarily invests in North America, with a strong preference for under-ventured markets, particularly in the Midwest. Arboretum Ventures has a portfolio of over 60 companies, showcasing its commitment to supporting innovative healthcare solutions. The firm emphasizes collaboration with entrepreneurs and provides strategic guidance, leveraging its extensive network to help portfolio companies scale effectively.
Notable milestones include successful exits from companies such as NxThera, Si-Bone, and NeuMoDx Molecular, demonstrating Arboretum's ability to identify and nurture high-potential healthcare startups. The firm operates from its office in Ann Arbor, which serves as a hub for its investment activities.
Arboretum Ventures invests across various sectors within healthcare, including biotech, medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharmaceutical adjacencies. The firm primarily targets early-stage investments, focusing on Series A and B funding rounds. Arboretum Ventures seeks to capitalize on under-ventured markets, emphasizing geographic areas and sectors that have historically received less attention from investors.
The firm looks for capital-efficient companies that demonstrate innovative solutions to pressing healthcare challenges. Arboretum Ventures values founders with domain expertise and a clear vision for their products. The investment strategy is designed to improve patient outcomes while simultaneously reducing healthcare costs, aligning with the firm’s overarching thesis.
Arboretum Ventures typically engages in collaborative partnerships with its portfolio companies, providing not just capital but also strategic guidance and access to a robust network of industry contacts. This approach enhances the potential for success and scalability in the healthcare sector.
Arboretum Ventures has a diverse portfolio of over 60 companies, focusing on innovative healthcare solutions. Notable portfolio companies include:
In addition to these current investments, Arboretum Ventures has achieved notable exits, including:
Jan Garfinkle - Founder & Managing Partner. Jan has over 21 years of experience in venture capital and is recognized as one of the most respected healthcare VCs in the Midwest. She has a strong track record of successful investments and exits.
Tom Shehab, MD - Managing Partner. Tom is a physician-investor with extensive experience in healthcare investments, focusing on medical devices and diagnostics.
Dan Kidle - Managing Partner. Dan brings a wealth of experience in venture capital and has been instrumental in driving the firm’s investment strategy.
Tim Petersen - Founder & Managing Partner. Tim has been with Arboretum since its inception and has played a key role in shaping its investment approach.
Paul McCreadie - Managing Partner & COO. Paul oversees the firm’s operations and has a strong background in finance and management.
Jeff Terrell - Partner. Jeff recently joined Arboretum and brings valuable insights from his previous roles in healthcare investment.
Nicole Vitullo - Venture Partner. Nicole has extensive experience in healthcare and venture capital, contributing to the firm’s strategic direction.
Charity Tarn - Principal. Charity focuses on sourcing and evaluating new investment opportunities within the healthcare sector.
James Kim - Associate. James supports the investment team in due diligence and portfolio management.
Sidh Chaudhary - Analyst. Sidh assists in research and analysis of potential investments.
Marcy Marshall - Chief Financial Officer. Marcy manages the firm’s financial operations and reporting.
Amanda Elder - Senior Vice President of Finance. Amanda oversees financial strategy and operations at Arboretum Ventures.
To pitch Arboretum Ventures, founders should use the [Investment Opportunity Submission Form](https://www.arboretumvc.com/contact/investment-opportunity/). It is essential to include a detailed overview of the business, including the problem being solved, the target market, and the competitive landscape. A well-structured pitch deck that outlines the business model, financial projections, and team qualifications is crucial.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In July 2023, Arboretum Ventures closed its sixth fund at $268 million, exceeding its target. This fund will continue to support early-stage healthcare companies across North America.
Recently, Arboretum has highlighted developments within its portfolio companies through blog posts, showcasing advancements in medical technology and partnerships. Notable updates include progress from Koya Medical, Francis Medical, and Pharaoh Neuro.
In March 2023, Arboretum Ventures welcomed Jeff Terrell as an investment partner, further strengthening its team and investment capabilities.
What are Arboretum Ventures' investment criteria?
Arboretum Ventures focuses on early-stage healthcare companies, particularly in sectors like medical devices, life science tools, diagnostics, and tech-enabled care delivery. They seek capital-efficient businesses that can improve patient outcomes and reduce healthcare costs.
How can I apply or pitch to Arboretum Ventures?
Founders can submit their investment opportunities through the [Investment Opportunity Submission Form](https://www.arboretumvc.com/contact/investment-opportunity/). It is advisable to provide a clear overview of the business model, market potential, and team expertise.
What makes Arboretum Ventures different from other VC firms?
Arboretum Ventures emphasizes collaboration with portfolio companies and has a strong focus on under-ventured markets, particularly in the Midwest. Their long-standing presence in the healthcare sector and successful track record of exits also set them apart.
What is the geographic scope of Arboretum Ventures' investments?
The firm primarily invests in North America, with a significant focus on the Midwest region, which has historically been under-ventured compared to coastal markets.
What is Arboretum Ventures' typical check size?
While specific check sizes are not publicly disclosed, Arboretum Ventures typically invests in the early-stage VC range, focusing on Series A and B funding rounds.
What kind of post-investment involvement does Arboretum Ventures have?
Arboretum Ventures provides strategic guidance and access to a robust network of industry contacts to help portfolio companies scale effectively. They emphasize collaboration and support throughout the growth journey.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.